A detailed history of Iron Financial, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Iron Financial, LLC holds 1,979 shares of ABT stock, worth $228,119. This represents 0.12% of its overall portfolio holdings.

Number of Shares
1,979
Previous 2,018 1.93%
Holding current value
$228,119
Previous $209,000 7.66%
% of portfolio
0.12%
Previous 0.12%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$100.07 - $118.13 $3,902 - $4,607
-39 Reduced 1.93%
1,979 $225,000
Q2 2024

Jul 29, 2024

BUY
$100.73 - $112.44 $6,446 - $7,196
64 Added 3.28%
2,018 $209,000
Q1 2024

Apr 23, 2024

BUY
$109.52 - $120.96 $547 - $604
5 Added 0.26%
1,954 $222,000
Q4 2023

Jan 19, 2024

BUY
$90.19 - $110.4 $175,780 - $215,169
1,949 New
1,949 $214,000
Q2 2023

Jul 24, 2023

BUY
$100.78 - $112.29 $195,613 - $217,954
1,941 New
1,941 $211,000
Q4 2022

Feb 14, 2023

SELL
$95.06 - $111.52 $7,129 - $8,364
-75 Reduced 1.87%
3,936 $432,000
Q3 2022

Nov 14, 2022

SELL
$96.76 - $112.03 $313,792 - $363,313
-3,243 Reduced 44.71%
4,011 $388,000
Q2 2022

Jul 27, 2022

SELL
$102.07 - $123.37 $30,110 - $36,394
-295 Reduced 3.91%
7,254 $788,000
Q1 2022

May 04, 2022

BUY
$114.02 - $139.04 $87,339 - $106,504
766 Added 11.29%
7,549 $894,000
Q4 2021

Feb 11, 2022

BUY
$115.53 - $141.46 $23,452 - $28,716
203 Added 3.09%
6,783 $955,000
Q3 2021

Nov 02, 2021

BUY
$116.66 - $129.06 $457,657 - $506,302
3,923 Added 147.65%
6,580 $777,000
Q2 2021

Jul 28, 2021

SELL
$105.79 - $124.53 $101,558 - $119,548
-960 Reduced 26.54%
2,657 $308,000
Q1 2021

May 07, 2021

SELL
$108.84 - $128.23 $31,128 - $36,673
-286 Reduced 7.33%
3,617 $433,000
Q4 2020

Jan 13, 2021

SELL
$105.0 - $114.42 $18,480 - $20,137
-176 Reduced 4.31%
3,903 $427,000
Q3 2020

Nov 09, 2020

BUY
$91.64 - $111.29 $1,924 - $2,337
21 Added 0.52%
4,079 $444,000
Q2 2020

Jul 15, 2020

SELL
$76.57 - $98.0 $5,206 - $6,664
-68 Reduced 1.65%
4,058 $371,000
Q1 2020

Apr 20, 2020

SELL
$62.82 - $91.86 $32,415 - $47,399
-516 Reduced 11.12%
4,126 $326,000
Q4 2019

Jan 30, 2020

BUY
$78.51 - $87.4 $9,970 - $11,099
127 Added 2.81%
4,642 $403,000
Q3 2019

Oct 21, 2019

SELL
$81.84 - $88.74 $8,184 - $8,874
-100 Reduced 2.17%
4,515 $378,000
Q2 2019

Aug 02, 2019

SELL
$72.88 - $85.0 $12,243 - $14,280
-168 Reduced 3.51%
4,615 $369,000
Q1 2019

May 08, 2019

BUY
$66.22 - $80.06 $60,789 - $73,495
918 Added 23.75%
4,783 $382,000
Q4 2018

Jan 15, 2019

BUY
$65.56 - $74.27 $12,063 - $13,665
184 Added 5.0%
3,865 $280,000
Q3 2018

Oct 18, 2018

BUY
$60.81 - $73.36 $21,040 - $25,382
346 Added 10.37%
3,681 $270,000
Q2 2018

Jul 30, 2018

BUY
$57.57 - $63.54 $191,995 - $211,905
3,335 New
3,335 $203,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $202B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Iron Financial, LLC Portfolio

Follow Iron Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Iron Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Iron Financial, LLC with notifications on news.